References
- World Health Organization. Clinical diagnosis. In: Dengue Haemorrhagic Fever, Diagnosis, Treatment, Prevention and Control, 2nd edn. Geneva: WHO, 1997; 12–23.
- World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: WHO, 2009.
- Chuansumrit A, Chaiyaratana W, Pongthanapisith V, Tangnararatchakit K, Lertwonggrath S, Yoksan S. The use of dengue nonstructural protein 1 antigen for the early diagnosis during the febrile stage in patients with dengue infection. Pediatr Infect Dis J. 2008;27:43–8.
- Chuansumrit A, Chaiyaratana W, Tangnararatchakit K, Yoksan S, Flamand M, Sakuntabhai A. Dengue nonstructural protein 1 antigen in the urine as a rapid and convenient diagnostic test during the febrile stage in patients with dengue infection. Diagn Microbiol Infect Dis. 2011;71:467–9.
- Pongtanakul B, Narkbunnam N, Veerakul G, Sanpakit K, Viprakasit V, Tanphaichitr V, et al.. Dengue hemorrhagic fever in patients with thalassemia. J Med Assoc Thai. 2005;88 (suppl 8):S80–5.
- Chuansumrit A, Tangnararatchakit K, Sirachainan N, Pakakasama S, Hongeng S, Chaiyaratana W, et al.. Dengue infection in hematologic-oncologic pediatric patients: aggravation to anemia and bleeding risk. Southeast Asian J Trop Med Public Health. 2012;43:311–22.
- Natesirinilkul R, Tantiworawit A, Charoenkwan P. Clinical course of dengue in patients with thalassemia. Paediatr Int Child Health. 2013;33:
- Buthep P, Chunhakan S. Tangnararatchakit K, Yoksan S, Pattanapanyasa K, Chuansumrit A. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. Pediatr Infect Dis J. 2006;25:894–7.
- Chuansumrit A, Tangnararatchakit K. Dengue hemorrhagic fever. In: , Okpala I, Johnson C, Synopsis of Hematology. Charleston, SC: CreateSpace, 2010; 219–35.